Search Results

Displaying Results 5601-5625 of 7014 "'MASS'"

Dec 11, 2025, 16:04 ET FDA Clears NUZ-001 for Entry into HEALEY ALS Platform Trial

dedicated to advancing innovative treatments for neurodegenerative diseases, is pleased to announce that the Sean M. Healey & AMG Center for ALS at Mass General Brigham has received clearance from the US Food and Drug Administration (FDA) to proceed with Neurizon's NUZ-001 regimen in the HEALEY ALS Platform

More news about: Neurizon Therapeutics Limited


Dec 11, 2025, 15:49 ET FDA Clears NUZ-001 for Entry into HEALEY ALS Platform Trial

dedicated to advancing innovative treatments for neurodegenerative diseases, is pleased to announce that the Sean M. Healey & AMG Center for ALS at Mass General Brigham has received clearance from the US Food and Drug Administration (FDA) to proceed with Neurizon's NUZ-001 regimen in the HEALEY ALS Platform

More news about: Neurizon Therapeutics Limited


Dec 11, 2025, 13:07 ET Veteran Ventures Capital Announces Investment in Vatn Systems, Supporting a New Era of Scalable Undersea Autonomy

innovation VVC was created to support," said Derren Burrell, Founder and Managing Partner of Veteran Ventures Capital. "Their team is fielding the undersea mass our national security enterprise urgently needs, and they're doing it with a level of technical rigor and operational intuition that's rare in this

More news about: Veteran Ventures Capital


Dec 11, 2025, 13:06 ET Pillar Biosciences and AstraZeneca Expand Liquid Biopsy Access Partnership to China

NATICK, Mass., Dec. 8, 2025 /PRNewswire/ -- Pillar Biosciences announced today an expansion of its existing laboratory access program with AstraZeneca for NGS-based kitted liquid biopsy tumor profiling to include China.

More news about: Pillar Biosciences, Inc.


Dec 11, 2025, 11:38 ET Rivergate Marketing Enhances Consulting Offerings With GTM Strategy Workshops

Go-to-Market Strategy Workshops for system integrators and industrial automation companies.ARLINGTON, Mass., Dec. 11, 2025 /PRNewswire/ -- 

More news about: Rivergate Marketing


Dec 11, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Cepton, Inc. and Certain Officers - CPTN

("Koito") (the "Koito Acquisition" or the "Merger") (as described below), Cepton was an electronics company focused on the deployment of high performance, mass-market light detection and ranging ("lidar") technologies to deliver safety and autonomy across the Automotive and Smart Infrastructure markets.  The

More news about: Pomerantz LLP


Dec 11, 2025, 09:30 ET Mitsubishi Chemical Group and Boston Materials Form Strategic Collaboration to Advance Semiconductor Packaging with Breakthrough Liquid Metal Thermal Materials

BILLERICA, Mass., Dec. 11, 2025 /PRNewswire/ -- Mitsubishi Chemical Group (MCG), a leading global provider of advanced materials, and Boston Materials, Inc., a manufacturer of advanced energy transfer materials, today announced

More news about: Boston Materials


Dec 11, 2025, 09:15 ET ETQ Ranked as Front Runner in LNS Research Enterprise Quality Management Software Solution Selection Matrix 2025

ETQ Recognized as 'More Advanced Software Provider' in EQMS SpaceBURLINGTON, Mass., Dec. 11, 2025 /PRNewswire/ --

More news about: ETQ, LLC


Dec 11, 2025, 09:00 ET Cellid and Jig.jp Jointly Develop AR Glasses

will jointly develop AR glasses equipped with Cellid's plastic waveguides (AR glass lenses) – the only domestically mass-produced version – for the Sabae-designed AR glasses being developed and sold by jig.jp Inc. (Headquarters: Sabae City,

More news about: Cellid, Inc.


Dec 11, 2025, 09:00 ET Five Leading Cancer Centers Unite to Target CD123 and Eradicate Hidden Leukemia Cells

next-generation MRD testing to track residual disease and uncover vulnerabilities in leukemia cellsCAMBRIDGE, Mass., Dec. 11, 2025 /PRNewswire/ -- Acute myeloid leukemia (AML) is an aggressive blood cancer, with overall survival

More news about: Break Through Cancer


Dec 11, 2025, 08:54 ET DEADLINE NEXT WEEK: Berger Montague Advises MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors to Contact the Firm Before December 15, 2025

(267)764-4865.About Berger MontagueBerger Montague is one of the nation's preeminent law firms focusing on complex civil litigation, class actions, and mass torts in federal and state courts throughout the United States. With more than $2.4 billion in 2025 post-trial judgments alone, the Firm is a leader

More news about: Berger Montague


Dec 11, 2025, 08:52 ET K2 Space Raises $250M at $3B Valuation to Roll Out a New Class of High-Capability Satellites

science fiction:AI scale compute on orbitHigh-throughput networks spanning orbits – and planetsMass-produced giant telescopes to vastly expand scientific return from across the solar system and beyond"Our north star is simple," said

More news about: K2 Space


Dec 11, 2025, 08:34 ET SHOPLINE Partners with LaunchBoom to Power Seamless Crowdfunding-to-E-Commerce Growth for Product Creators

GrowthLaunchBoom has helped more than a thousand creators validate products, sell their first 3,000+ units, and generate six to seven-figure pre-sales before mass production. By pairing that early traction with SHOPLINE's powerful commerce infrastructure, creators can now move from launch to long-term scale with

More news about: SHOPLINE


Dec 11, 2025, 08:30 ET Fescaro sees rising demand for automotive cybersecurity solutions

entire 15-year lifecycle of these keys, ensuring that only authorized users have control permissions.As cybersecurity becomes a prerequisite for mass production, automakers are increasingly requiring ECU developers to integrate KMS into their manufacturing lines. With around 100 million vehicles produced

More news about: The Korea Herald


Dec 11, 2025, 08:30 ET WERFEN APPLAUDS SIGNIFICANT PUBLICATION URGING ACTION ON THE RISKS OF UNDETECTED HEMOLYSIS

Calling for Greater Education, Testing, and Prevention of In Vitro Hemolysis in High-Risk SettingsBEDFORD, Mass., Dec. 11, 2025 /PRNewswire/ -- Werfen today announced their commendation for the recent publication of a significant,

More news about: Werfen


Dec 11, 2025, 08:00 ET Ghost Robotics® Unveils New Manipulator Arm for the Vision 60 Q-UGV®

enabling door access, the robot is built for both worlds."Key SpecificationsFull Extension: 1 meter (3.3 ft)Mass: 10.6 kg (23.4 lbs.)Gripping Force: 11.3 kg (25 lbs.)Payload: 3.75 kg (8.3 lbs.) at 50 cm (19.7 in), continuousOperating Temperature:

More news about: Ghost Robotics


Dec 11, 2025, 08:00 ET Watts Law Firm Files Landmark Lawsuit Alleging Texas Instruments, AMD, Intel, and Mouser Electronics Supplied Technology Used in Iranian-Russian Drones and Missiles that Killed Ukrainian Civilians

WASHINGTON, Dec. 11, 2025 /PRNewswire/ -- Civil rights and mass-tort attorneys from Watts Law Firm LLP and BakerHostetler LLP today announced the filing of a major lawsuit in Texas state court on behalf

More news about: Watts Law Firm LLP


Dec 11, 2025, 07:39 ET Bitdeer Technologies Group Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - BTDR

2026 CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. Bitdeer concealed the fact that mass production of the SEAL04 chip would not being in Q2 2025 as expected. The Company misled investors about the status of the overall SEALMINER A4 project.

More news about: DJS Law Group LLP


Dec 11, 2025, 07:07 ET Odyssey Functional Energy Expands Across Major U.S. Airports Nationwide with CIBO Express Deal

Kosher, and made with real fruit juice.Odyssey is available in over 9,200 retail locations nationwide, with continued expansion across natural, mass, and club channels. Founded by entrepreneur Scott Frohman in 2022, Odyssey is more than a beverage, it's a smarter way to energize. Fuel your mind. Elevate

More news about: Odyssey Functional Energy


Dec 11, 2025, 06:30 ET Legal Bay Presettlement Lawsuit Funding Recognized as a Top 3 Financial Services Provider by BusinessRate

funds all types of legal claims, including personal injury, wrongful termination, workplace harassment, medical malpractice, motor vehicle accidents, mass torts, and more.As the demand for pre-settlement funding grows nationwide, Legal-Bay remains focused on providing compassionate, premium service

More news about: Legal-Bay, LLC


Dec 11, 2025, 06:30 ET NEVADA KING ANNOUNCES FULLY FUNDED 20,000M, PHASE 4 EXPLORATION PROGRAM DESIGNED TO ADVANCE MULTIPLE REGIONAL TARGETS IDENTIFIED IN PHASE 3

ounces already defined, Atlanta stands out as one of the rare and potentially large-scale gold systems in the U.S. that sits on the cusp of critical mass. Phase 4 is laser-focused on pushing us over that threshold, and Silver Park East represents the most immediate opportunity to grow the resource."Justin

More news about: Nevada King Gold Corp.


Dec 11, 2025, 04:02 ET Artificial Flower Market to Reach $5.6 billion, Globally, by 2034 at 6.6% CAGR: Allied Market Research

suitable for both indoor and outdoor use. In addition, the balance between affordability and visual appeal has made polyester the preferred choice for mass production, catering to a wide range of consumer preferences across residential, commercial, and event décor applications.The commercial segment

More news about: Allied Market Research


Dec 11, 2025, 00:44 ET European researchers developed energy-efficient machine vision inspired by human eyesight and the brain

with people moving around them. Simultaneously, the equipment must be small, consume little energy, and be built with moderate costs suitable for a mass product," says Mika Laiho, Chief Technology Officer at Kovilta.Applications from industry to securityThe solutions developed

More news about: VTT Info


Dec 10, 2025, 16:01 ET Nuvalent Appoints Ron Squarer to Board of Directors

CAMBRIDGE, Mass., Dec. 10, 2025 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted

More news about: Nuvalent, Inc.


Dec 10, 2025, 15:08 ET Privo Technologies Begins Dosing PRV131 in Arm 3 Of Clinical Study CLN-004, A First-In-Class Cisplatin Intratumoral Injectable Targeting Oral Cavity Cancer

high concentrations of cisplatin directly to tumors, while minimizing systemic exposure.BOSTON, Mass., Dec. 10, 2025 /PRNewswire/ -- Privo Technologies, Inc., today announced that the first patient has been dosed

More news about: Privo Technologies


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.